Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Doxapram hydrochloride
Drug ID BADD_D00717
Description A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
Indications and Usage For use as a temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.
Marketing Status Prescription; Discontinued
ATC Code R07AB01
DrugBank ID DB00561
KEGG ID D01872
MeSH ID D004315
PubChem ID 64647
TTD Drug ID D0M7BT
NDC Product Code 51662-1404; 0641-6018
Synonyms Doxapram | Dopram | Doxapram Hydrochloride | Hydrochloride, Doxapram | Docatone
Chemical Information
Molecular Formula C24H31ClN2O2
CAS Registry Number 113-07-5
SMILES CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hyperventilation22.02.01.006; 19.01.02.004--Not Available
Hypoventilation22.02.01.007--Not Available
Laryngospasm22.04.02.002--
Muscle contractions involuntary17.05.03.001; 15.05.03.008--Not Available
Muscle spasticity17.05.03.007; 15.05.04.011--
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Nausea07.01.07.001--
Paraesthesia17.02.06.005--
Phlebitis24.05.03.001; 12.02.01.002--
Pruritus23.03.12.001--
Psychomotor hyperactivity17.01.02.011; 19.11.02.003--Not Available
Pyrexia08.05.02.003--
Red blood cell count13.01.05.020--Not Available
Seizure17.12.03.001--
Tachypnoea22.02.01.014--Not Available
Urinary retention20.02.02.011--
Ventricular fibrillation02.03.04.008--
Ventricular tachycardia02.03.04.010--
Vomiting07.01.07.003--
White blood cell count decreased13.01.06.012--
Infusion25.01.02.010--Not Available
The 2th Page    First    Pre   2    Total 2 Pages